P05121 (PAI1_HUMAN) Homo sapiens (Human)
Plasminogen activator inhibitor 1 UniProtKBInterProSTRINGInteractive Modelling
402 aa; Sequence (Fasta) ; (Isoform 2)
Available Structures
29 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal Structure of Stabilized Active Plasminogen Activator Inhibitor-1 (PAI-1-W175F) in Complex w… |
Heteromer | |||||
| Assess | ||||||
| Crystal Structure of Stabilized Active Plasminogen Activator Inhibitor-1 (PAI-1-stab) in Complex wi… |
Heteromer | |||||
| Assess | ||||||
| CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1 |
Heteromer | |||||
| Assess | ||||||
| Crystal Structure of Small Molecule Inhibitor TM5484 Bound to Stabilized Active Plasminogen Activat… |
Heteromer | 1×RV2; | ||||
| Assess | ||||||
| Crystal Structure of a Michaelis Complex between Plasminogen Activator Inhibitor-1 and Urokinase-ty… |
Heteromer P00749; | 2×SO4; | ||||
| Assess | ||||||
| plasminogen activator inhibitor-1 complex with somatomedin B domain of vitronectin |
Heteromer P04004; | |||||
| Assess | ||||||
| Crystal Structure of Stabilized Active Plasminogen Activator Inhibitor-1 (PAI-1-stab) in Complex wi… |
Heteromer | |||||
| Assess | ||||||
| Discovery and characterisation of an antibody that selectively modulates the inhibitory activity of… |
Heteromer | |||||
| Assess | ||||||
| Structure of tPA and PAI-1 |
Heteromer P00750; | 2×GOL; | ||||
| Assess | ||||||
| Crystal Structure of Stabilized Active Plasminogen Activator Inhibitor-1 (PAI-1-W175F) in Complex w… |
Heteromer | |||||
| Assess | ||||||
| Michaelis complex of tPA-S195A:PAI-1 |
Heteromer P00750; | 4×GOL; 1×PGE; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR-1 | homo-2-mer | |||||
| Assess | ||||||
| High resolution structure of a stable Plasminogen activator inhibitor type-1 in its protease cleave… | monomer | |||||
| Assess | ||||||
| 1.8A Resolution Structure of Latent Plasminogen Activator Inhibitor-1(PAI-1) | monomer | 4×DMS; 1×ACY; | ||||
| Assess | ||||||
| LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) | monomer | |||||
| Assess | ||||||
| Plasminogen activator inhibitor type-1 in complex with the inhibitor AZ3976 | monomer | 1×TB7; | ||||
| Assess | ||||||
| PLASMINOGEN ACTIVATOR INHIBITOR-1 | monomer | |||||
| Assess | ||||||
| High quality structure of cleaved PAI-1-stab | monomer | |||||
| Assess | ||||||
| Crystal Structure of Small Molecule Inhibitor TM5484 Bound to Stabilized Active Plasminogen Activat… | monomer | 1×RV2; | ||||
| Assess | ||||||
| HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE | monomer | 1×NAG; 1×NAG; | ||||
| Assess | ||||||
| Human very long half life Plasminogen Activator Inhibitor type-1 | monomer | 1×NAG; 1×NAG; | ||||
| Assess | ||||||
| ACTIVE FORM OF HUMAN PAI-1 | monomer | 1×CL; | ||||
| Assess | ||||||
| Crystal structure of plasminogen activator inhibitor-1 in a metastable active conformation. | monomer | 1×ZN; 1×CL; | ||||
| Assess | ||||||
| Crystal Structure of PAI-1 in Complex with Gallate | monomer | 1×GDE; | ||||
| Assess | ||||||
| Crystal Structure of a novel small molecule inactivator bound to plasminogen activator inhibitor-1 | monomer | 1×SO4; 1×EDO; | ||||
| Assess | ||||||
| Crystal Structure of a novel small molecule inactivator bound to plasminogen activator inhibitor-1 | monomer | |||||
| Assess | ||||||
| Crystal structure of plasminogen activator inhibitor-1 in a metastable active conformation. | monomer | 1×CL; | ||||
| Assess | ||||||
| A novel PAI-I inhibitor and its structural mechanism | monomer | |||||
| Assess | ||||||
| Plasminogen activator inhibitor-1 | monomer | |||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3cvm.1.A | monomer | 0.83 | 98.69 | |||
| Assess | ||||||
1 SWISS-MODEL model built on isoform sequence
| Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 2 | 3q02.2.A | monomer | 0.81 | 1×ZN; | 99.73 | |
| Assess | ||||||